[go: up one dir, main page]

MX2020011664A - Formulacion vaporizable. - Google Patents

Formulacion vaporizable.

Info

Publication number
MX2020011664A
MX2020011664A MX2020011664A MX2020011664A MX2020011664A MX 2020011664 A MX2020011664 A MX 2020011664A MX 2020011664 A MX2020011664 A MX 2020011664A MX 2020011664 A MX2020011664 A MX 2020011664A MX 2020011664 A MX2020011664 A MX 2020011664A
Authority
MX
Mexico
Prior art keywords
vaporisable formulation
cooling agent
vaporisable
formulation
menthol
Prior art date
Application number
MX2020011664A
Other languages
English (en)
Inventor
Klaus Mathie
Pena Maria Montserrat Sanchez
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Publication of MX2020011664A publication Critical patent/MX2020011664A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/34—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/38—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A24B15/406—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms in a five-membered ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Mechanical Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se proporciona una formulación vaporizable que comprende (i) uno o más disolventes; y (ii) menos de aproximadamente 1% en peso de un agente de enfriamiento con base en el peso de la formulación vaporizable, en donde el agente de enfriamiento se volatiliza a una temperatura más alta que el mentol a presión atmosférica. Asimismo, se proporciona una formulación vaporizable que comprende (i) uno o más disolventes; y (ii) menos de aproximadamente 12% en peso de un agente de enfriamiento con base en el peso de la formulación vaporizable, en donde el agente de enfriamiento se volatiliza a una temperatura más alta que el mentol a presión atmosférica y es un compuesto de la fórmula (I) o una sal y/o un solvato del mismo como se define en el presente documento.
MX2020011664A 2018-05-03 2019-05-03 Formulacion vaporizable. MX2020011664A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1807305.6A GB201807305D0 (en) 2018-05-03 2018-05-03 Vaporisable formulation
PCT/GB2019/051244 WO2019211629A1 (en) 2018-05-03 2019-05-03 Vaporisable formulation

Publications (1)

Publication Number Publication Date
MX2020011664A true MX2020011664A (es) 2020-12-10

Family

ID=62598261

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011664A MX2020011664A (es) 2018-05-03 2019-05-03 Formulacion vaporizable.

Country Status (13)

Country Link
US (1) US20210368850A1 (es)
EP (1) EP3787429A1 (es)
JP (2) JP7258911B2 (es)
KR (2) KR102594623B1 (es)
CN (1) CN112074201A (es)
AU (2) AU2019264022A1 (es)
BR (1) BR112020021341A2 (es)
CA (2) CA3190409A1 (es)
GB (1) GB201807305D0 (es)
IL (2) IL305868B2 (es)
MX (1) MX2020011664A (es)
MY (1) MY203314A (es)
WO (1) WO2019211629A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023503775A (ja) * 2019-12-02 2023-02-01 ジェイティー インターナショナル エス．エイ． 組成物の５０重量％未満の１，３－プロパンジオールを含むｅリキッド組成物
GB202006633D0 (en) * 2020-05-05 2020-06-17 Nicoventures Holdings Ltd Aerosol generating material
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
GB202110541D0 (en) * 2021-07-22 2021-09-08 Nicoventures Trading Ltd Delivery system
EP4463019A1 (en) * 2022-01-14 2024-11-20 Nicoventures Trading Limited Aerosolisable material

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5097886A (es) * 1973-12-28 1975-08-04
JP2005512554A (ja) 2001-12-19 2005-05-12 ベクター・タバコ・インコーポレーテッド タバコ製品に清涼効果を付与する方法および組成物
US6897195B2 (en) * 2002-07-24 2005-05-24 Nanjing Zhongshi Chemical Co. Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent
US7767243B2 (en) * 2004-12-29 2010-08-03 WH. Wrigley Jr. Company Combinations of cooling agents for use in confections
WO2007041035A2 (en) 2005-09-30 2007-04-12 Wm. Wrigley Jr. Company Oral composition and method for stress reduction associated with smoking cessation
US20070178123A1 (en) * 2006-01-27 2007-08-02 Deborah Levenson Flavor-enhancing compositions, method of manufacture, and methods of use
KR20090113829A (ko) 2006-12-20 2009-11-02 지보당 네덜란드 서비시즈 비.브이. Ｎ-치환된-ｐ-멘탄-3-카복스아미드 및 이의 용도
JP2009148233A (ja) 2007-12-21 2009-07-09 Japan Tobacco Inc 喫煙物品
EP2296759B1 (en) * 2008-05-22 2019-10-02 Givaudan SA Cooling composition
DE102010002558A1 (de) 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
ES2377785B2 (es) 2010-09-08 2012-09-26 Universidad Miguel Hernández De Elche Composición farmacéutica para el tratamiento del ojo seco.
US9282772B2 (en) * 2012-01-31 2016-03-15 Altria Client Services Llc Electronic vaping device
MX384606B (es) * 2013-05-06 2025-03-12 Juul Labs Inc Formulaciones de sal de nicotina para dispositivos de aerosol y métodos de los mismos.
AU2014276460A1 (en) * 2013-06-04 2015-12-24 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
US9877511B2 (en) * 2013-07-24 2018-01-30 Altria Client Services Llc Electronic smoking article
EA201692191A1 (ru) * 2014-04-30 2017-03-31 Олтриа Клайент Сервисиз Ллк Жидкая рецептура аэрозоля электронного курительного изделия
JP6061900B2 (ja) 2014-07-24 2017-01-18 長谷川香料株式会社 Ｗｓ−１２の微粒子およびこれを含有する冷感剤組成物
TWI693031B (zh) 2015-04-30 2020-05-11 瑞士商菲利浦莫里斯製品股份有限公司 包含具高通氣度之可卸式清新劑遞送元件的氣溶膠產生物件
GB2544468A (en) * 2015-11-12 2017-05-24 Jaytee Biosciences Ltd Liquid formulation
US20170172204A1 (en) * 2015-12-18 2017-06-22 Altria Client Services Llc Strength enhancers and method of achieving strength enhancement in an electronic vapor device
US20160376263A1 (en) * 2016-07-26 2016-12-29 Senomyx, Inc. Bitter taste modifiers including substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones and compositions thereof
JP6770864B2 (ja) 2016-09-30 2020-10-21 アース製薬株式会社 スプレー型芳香剤
CN106962971A (zh) * 2017-04-11 2017-07-21 深圳瀚星翔科技有限公司 电子烟烟油及其制备方法

Also Published As

Publication number Publication date
IL277973B1 (en) 2023-10-01
KR102594623B1 (ko) 2023-10-25
IL277973B2 (en) 2024-02-01
GB201807305D0 (en) 2018-06-20
EP3787429A1 (en) 2021-03-10
JP7258911B2 (ja) 2023-04-17
IL305868B2 (en) 2025-03-01
AU2022218470A1 (en) 2022-09-08
CN112074201A (zh) 2020-12-11
MY203314A (en) 2024-06-24
RU2020136071A3 (es) 2022-05-04
IL305868A (en) 2023-11-01
JP2021523690A (ja) 2021-09-09
JP2023085453A (ja) 2023-06-20
BR112020021341A2 (pt) 2021-01-19
CA3099021A1 (en) 2019-11-07
AU2019264022A1 (en) 2020-10-29
IL305868B1 (en) 2024-11-01
KR20230151065A (ko) 2023-10-31
CA3190409A1 (en) 2019-11-07
AU2022218470B2 (en) 2024-07-04
NZ768771A (en) 2024-07-05
US20210368850A1 (en) 2021-12-02
RU2020136071A (ru) 2022-05-04
JP7682942B2 (ja) 2025-05-26
IL277973A (en) 2020-11-30
KR20200136033A (ko) 2020-12-04
WO2019211629A1 (en) 2019-11-07

Similar Documents

Publication Publication Date Title
MY203314A (en) Vaporisable formulation
SA521422143B1 (ar) 15-pgdh مثبط
GEAP202215671A (en) Microbiocidal thiazole derivatives
GEAP202215378A (en) Microbiocidal thiazole derivatives
GEP20227428B (en) Heterocyclic compounds as immunomodulators
PH12018501099A1 (en) Novel biphenyl compound or salt thereof
SA520411524B1 (ar) مركبات تنشيط القسيم العضلي ثنائي الأميد واستخداماتها
MX2024013464A (es) Antagonistas del receptor de tipo toll 7/8 (tlr7/8) y usos de los mismos
TW201613568A (en) Pharmaceutical composition comprising novel hydroxamic acid derivative or salt thereof
MX2022011896A (es) Composiciones oftalmicas.
NZ608846A (en) Aryloxyurea compound and pest control agent
MX388612B (es) Intermediarios para preparar herbicidas de piridazinona y proceso para prepararlos.
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof
MX2021003430A (es) Nuevos oxadiazoles.
MX2020006370A (es) Pirazolopiridina-diamidas, su uso como insecticida y procesos para prepararlas.
CR20200267A (es) Polimorfos
AU2017263385A1 (en) Glyphosate formulations containing amidoalkylamine surfactants
PH12021551103A1 (en) 1,3,4-oxadiazolone compound and medicine
MX2019011182A (es) Combinacion de derivados de isoindolinona con sgi-110.
EP4606435A3 (en) Pharmaceutical composition comprising poorly soluble basic agent
MX2017007385A (es) Estabilizacion de nanoparticulas hexagonales de nitruro de boro.
MX381234B (es) Agente preventivo y/o terapéutico de enfermedad inmune.
MY177032A (en) Aqueous composition
MX2019006939A (es) Preparacion liquida parenteral que comprende compuesto de carbamato.
NZ751777A (en) Pharmaceutical composition and methods of uses